← Leaderboards
Mihaela Gueorguieva Gadjeva
Brigham And Women'S Hospital
$4,453,699
Attributed
$4,453,699
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $562.1K · FY2010–20$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,453,699 · 2
By mechanism
R01$3,976,449 · 1
R21$477,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Joshua M Shulman$14,788,000
- Vanessa Mitsialis$750,700
- Francisco J. Quintana$15,804,456
- Guo-Ping Shi$19,551,120
- Oleg Butovsky$13,581,013
Others in their field
Top investigators on “Keratitis”
- Eric Pearlman · Case Western Reserve University$18,563,844
- Linda D Hazlett · Wayne State University$13,819,822
- David A. Leib · Dartmouth College$13,652,659
- Homayon Ghiasi · Cedars-Sinai Medical Center$13,521,001
- Deepak Shukla · University Of Illinois At Chicago$12,900,859
- Keri Hammel · The Emmes Company, Llc$11,933,187
Research focus
KeratitisInflammationPseudomonas AeruginosaTraumaInfectionComplicationContact LensesAntibiotic TherapyImmune ResponsePathogenVisionCorneaTreatment StrategyBaseBactericideImmunityBlindnessComplementMediatingPropertyInflammatoryInflammatory ResponseInhibitor/AntagonistHealed
Grant awards (12)
Novel treatment strategies to regulate inflammation during P.aeruginosa keratitis$439,875
R01 · FY2020 · EY · contact PI
Novel treatment strategies to regulate inflammation during P.aeruginosa keratitis$122,221
R01 · FY2020 · EY · contact PI
Novel treatment strategies to regulate inflammation during P.aeruginosa keratitis$439,875
R01 · FY2019 · EY · contact PI
Novel treatment strategies to regulate inflammation during P.aeruginosa keratitis$439,875
R01 · FY2018 · EY · contact PI
Novel treatment strategies to regulate inflammation during P.aeruginosa keratitis$439,875
R01 · FY2017 · EY · contact PI
Novel treatment strategies to regulate inflammation during P.aeruginosa keratitis$426,625
R01 · FY2016 · EY · contact PI
Novel treatment strategies to regulate inflammation during P.aeruginosa keratitis$418,092
R01 · FY2015 · EY · contact PI
Novel treatment strategies to regulate inflammation during P.aeruginosa keratitis$418,092
R01 · FY2014 · EY · contact PI
Novel treatment strategies to regulate inflammation during P.aeruginosa keratitis$405,294
R01 · FY2013 · EY · contact PI
Novel treatment strategies to regulate inflammation during P.aeruginosa keratitis$426,625
R01 · FY2012 · EY · contact PI
Inhibition of MIF is protective against Pseudomonas aeruginosa-eye infection$299,250
R21 · FY2011 · EY · contact PI
Inhibition of MIF is protective against Pseudomonas aeruginosa-eye infection$178,000
R21 · FY2010 · EY · contact PI